BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2200
-0.0080 (-3.51%)
Apr 23, 2026, 2:09 PM EDT - Market open
BioRestorative Therapies Employees
As of December 31, 2025, BioRestorative Therapies had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees increased by 3 or 27.27% compared to the previous year.
Employees
14
Change (1Y)
3
Growth (1Y)
27.27%
Revenue / Employee
$25,693
Profits / Employee
-$1,017,284
Market Cap
5.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | 3 | 27.27% | 13 | 1 |
| Dec 31, 2024 | 11 | 0 | - | 11 | 0 |
| Dec 31, 2023 | 11 | 1 | 10.00% | 11 | 0 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2021 | 7 | 2 | 40.00% | 7 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 47 |
| CollPlant Biotechnologies | 39 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 10 |
| Dermata Therapeutics | 9 |
| Ernexa Therapeutics | 7 |
BRTX News
- 2 days ago - BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform - GlobeNewsWire
- 16 days ago - BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform - GlobeNewsWire
- 24 days ago - BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease - GlobeNewsWire
- 5 weeks ago - BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease - GlobeNewsWire
- 7 weeks ago - BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 - GlobeNewsWire
- 2 months ago - BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs - GlobeNewsWire
- 2 months ago - BioRestorative Announces Closing of $5.0 Million Public Offering - GlobeNewsWire
- 2 months ago - BioRestorative Announces Pricing of $5.0 Million Public Offering - GlobeNewsWire